Basic information
- Name:
1H-Indole-5-methanesulfonamide,3-[2-(dimethylamino)ethyl]-N-methyl-
- Superlist Name:
- Sumatriptan
- CAS No.:
103628-46-2
- Molecular Structure:
![Molecular Structure of 103628-46-2 (1H-Indole-5-methanesulfonamide,3-[2-(dimethylamino)ethyl]-N-methyl-)](http://www.lookchem.com/300w/2010/0612/103628-46-2.jpg)
- Formula:
- C14H21N3O2S
- Molecular Weight:
- 295.40
- Synonyms:
- 3-[2-(Dimethylamino)ethyl]-N-methyl-1H-indole-5-methanesulfonamide;GR 43175;GR 43175X;Alsuma;BRN 6930870;Sumatriptanum;UNII-8R78F6L9VO;1H-Indole-5-methanesulfonamide, 3-(2-(dimethylamino)ethyl)-N-methyl-;
- Density:
- 1.243 g/cm3
- Melting Point:
- 169-171 °C
- Boiling Point:
- 497.7 °C at 760 mmHg
- Flash Point:
- 254.8 °C
- Solubility:
- Water: 21.4 mg/mL
- Appearance:
- White to crystalline powder
- Hazard Symbols:
Xi- Risk Codes:
- 36/37/38
- Safety Description:
- 26 Details
Famous Chemical Enterprises
-
Livzon -
Total -
Shell -
Dupont -
Exxonmobil -
Akzonobel -
Basf -
Bayer -
BP
Please post your buying leads,so that our qualified suppliers will soon
contact you!
*Required Fields
Specification
The Sumatriptan with CAS registry number of 103628-46-2 is also known as . The IUPAC name is 1-[3-[2-(Dimethylamino)ethyl]-1H-indol-5-yl]-N-methylmethanesulfonamide. It belongs to product categories of . Its EINECS registry number is Active Pharmaceutical Ingredients; Sumatriptan; API's. In addition, the formula is C14H21N3O2S and the molecular weight is 295.40. This chemical is a white to crystalline powder. What's more, it is used for the treatment of migraine.
Physical properties about Sumatriptan are: (1)ACD/LogP: 0.67; (2)ACD/LogD (pH 5.5): -2.35; (3)ACD/LogD (pH 7.4): -1.21; (4)ACD/BCF (pH 5.5): 1; (5)ACD/BCF (pH 7.4): 1; (6)ACD/KOC (pH 5.5): 1; (7)ACD/KOC (pH 7.4): 1; (8)#H bond acceptors: 5; (9)#H bond donors: 2; (10)#Freely Rotating Bonds: 5; (11)Index of Refraction: 1.609; (12)Molar Refractivity: 82.35 cm3; (13)Molar Volume: 237.6 cm3; (14)Surface Tension: 52.7 dyne/cm; (15)Density: 1.243 g/cm3; (16)Flash Point: 254.8 °C; (17)Enthalpy of Vaporization: 76.57 kJ/mol; (18)Boiling Point: 497.7 °C at 760 mmHg; (19)Vapour Pressure: 4.83E-10 mmHg at 25 °C.
Preparation of Sumatriptan: it is prepared by reaction of nitrile compound. The reaction occurs in the solution of dimethylamine and methanol. Besides, the hydrogenation reaction needs catalyst 10% palladium-carbon at room temperature for 24 hours.

When you are using this chemical, please be cautious about it. As a chemical, it is irritating to eyes, respiratory system and skin. In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.
You can still convert the following datas into molecular structure:
1. Canonical SMILES: CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
2. InChI: InChI=1S/C14H21N3O2S/c1-15-20(18,
19)10-11-4-5-14-13(8-11)12(9-16-14)6-7-17(2)3/h4-5,8-9,15-16H,6-7,10H2,1-3H3
3. InChIKey: KQKPFRSPSRPDEB-UHFFFAOYSA-N
The toxicity data is as follows:
| Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
|---|---|---|---|---|---|
| man | TDLo | subcutaneous | 429ug/kg/2W-I (0.429mg/kg) | BEHAVIORAL: MUSCLE WEAKNESS | Lancet. Vol. 341, Pg. 1091, 1993. |
| man | TDLo | subcutaneous | 86mg/kg (86mg/kg) | CARDIAC: ARRHYTHMIAS (INCLUDING CHANGES IN CONDUCTION) CARDIAC: EKG CHANGES NOT DIAGNOSTIC OF ABOVE | British Medical Journal. Vol. 304, Pg. 1415, 1992. |
| mouse | LDLo | oral | > 500mg/kg (500mg/kg) | SENSE ORGANS AND SPECIAL SENSES: MYDRIASIS (PUPILLARY DILATION): EYE SKIN AND APPENDAGES (SKIN): "DERMATITIS, OTHER: AFTER SYSTEMIC EXPOSURE" BEHAVIORAL: ATAXIA | Human & Experimental Toxicology. Vol. 14, Pg. 959, 1995. |
| mouse | LDLo | subcutaneous | > 100mg/kg (100mg/kg) | SENSE ORGANS AND SPECIAL SENSES: MYDRIASIS (PUPILLARY DILATION): EYE SKIN AND APPENDAGES (SKIN): "DERMATITIS, OTHER: AFTER SYSTEMIC EXPOSURE" GASTROINTESTINAL: CHANGES IN STRUCTURE OR FUNCTION OF SALIVARY GLANDS | Human & Experimental Toxicology. Vol. 14, Pg. 959, 1995. |
| rat | LD | intravenous | > 20mg/kg (20mg/kg) | SENSE ORGANS AND SPECIAL SENSES: OTHER: EYE LUNGS, THORAX, OR RESPIRATION: RESPIRATORY STIMULATION SKIN AND APPENDAGES (SKIN): "DERMATITIS, OTHER: AFTER SYSTEMIC EXPOSURE" | Human & Experimental Toxicology. Vol. 14, Pg. 959, 1995. |
| rat | LD | subcutaneous | > 1gm/kg (1000mg/kg) | BEHAVIORAL: TREMOR SKIN AND APPENDAGES (SKIN): "DERMATITIS, OTHER: AFTER SYSTEMIC EXPOSURE" LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION | Human & Experimental Toxicology. Vol. 14, Pg. 959, 1995. |
| rat | LDLo | oral | > 2gm/kg (2000mg/kg) | SENSE ORGANS AND SPECIAL SENSES: LACRIMATION: EYE SKIN AND APPENDAGES (SKIN): "DERMATITIS, OTHER: AFTER SYSTEMIC EXPOSURE" BEHAVIORAL: ATAXIA | Human & Experimental Toxicology. Vol. 14, Pg. 959, 1995. |
| women | TDLo | subcutaneous | 120ug/kg (0.12mg/kg) | BEHAVIORAL: MUSCLE WEAKNESS | Lancet. Vol. 341, Pg. 1091, 1993. |
| women | TDLo | subcutaneous | 120ug/kg (0.12mg/kg) | CARDIAC: EKG CHANGES NOT DIAGNOSTIC OF ABOVE GASTROINTESTINAL: NAUSEA OR VOMITING CARDIAC: PULSE RATE INCREASE WITHOUT FALL IN BP | Annals of Internal Medicine. Vol. 129, Pg. 874, 1998. |
| women | TDLo | subcutaneous | 240ug/kg/1H-I (0.24mg/kg) | PERIPHERAL NERVE AND SENSATION: SENSORY CHANGE INVOLVING PERIPHERAL NERVE PERIPHERAL NERVE AND SENSATION: FLACCID PARALYSIS WITHOUT ANESTHESIA (USUALLY NEUROMUSCULAR BLOCKAGE) BEHAVIORAL: "HALLUCINATIONS, DISTORTED PERCEPTIONS" | Lancet. Vol. 343, Pg. 1105, 1994 |

